Cart summary

You have no items in your shopping cart.

KRAS G12C inhibitor 44

SKU: orb1685946

Description

KRAS G12C inhibitor 44 is a potent and orally bioavailable small molecule targeting the KRAS G12C mutation. It demonstrates strong anti-proliferative activity in cellular assays, such as with MIA PaCa-2 and H358 cells, and has shown efficacy in in vivo tumor models, supporting its use in oncology research.

Research Area

Pharmacology & Drug Discovery, Signal Transduction

Images & Validation

Key Properties

MW579.11
FormulaC31H36ClFN6O2
TargetRas,Others,Kras

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

KRAS G12C inhibitor 44 (orb1685946)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%